Fabomotizole hydrochloride

Overview

Fabomotizole (brand name Afobazole) is an anxiolytic drug launched in Russia in the early 2000s. It produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions. Its mechanism of action remains poorly defined however, with GABAergic, NGF- and BDNF-release-promoting, MT1 receptor agonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Fabomotizole was shown to inhibit MAO-A reversibly and there might be also some involvement with serotonin receptors. Clinical trials have shown fabomotizole to be well tolerated and reasonably effective for the treatment of anxiety. Experiments of mice have showed antimutagenic and antiteratogenic properties.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cardiovascular and blood system | Monoamine Oxidase

Product Information

• Catalog No.: B2693-463567
• CAS No.: 173352-39-1
• Molecular Formula: C15H22ClN3O2S
• Molecular Weight: 343.87
• Purity: >98%
• Storage: Store at 2-8 °C, under inert gas (nitrogen or Argon)
• Solubility: Soluble in DMSO, Ethanol

Source

Original product source